Clinical Trials Logo

Fluid Overload clinical trials

View clinical trials related to Fluid Overload.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04870073 Withdrawn - Clinical trials for Coronary Artery Disease

Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery

RAPPER-MAN
Start date: September 21, 2022
Phase: Phase 3
Study type: Interventional

Hemodilution reduces concentrations of blood constituents: concentration of hemoglobin, red blood cells (hematocrit), physiological ions and coagulation factors that can contribute to impaired hemostasis and increasing the risk of perioperative blood transfusions. This pilot study will assess the feasibility of a large RCT to evaluate 2 techniques for reducing hemodilution during cardiac surgery: 1) retrograde autologous priming and 2) intraoperative mannitol. The aim of this pilot trial is to demonstrate feasibility of a larger trial to evaluate whether retrograde autologous priming and/or mannitol are superior to conventional priming alone.

NCT ID: NCT04576806 Withdrawn - Sepsis Clinical Trials

Physiological Effects of 38°C vs. 22°C Fluid Therapy in Critically Ill Patients

Start date: April 30, 2021
Phase: N/A
Study type: Interventional

A randomized controlled clinical trial. 24 adult ICU patients will be recruited upon decision to administer fluid bolus of 500ml of crystalloid. The fluid will then be randomized to be infused at controlled room temperature or warmed to body temperature. Hemodynamic measurements will be made for 2 hours following the bolus, and laboratory values will be noted. The hypothesis is that part of the hemodynamic response will differed in response to cooling, and be larger in the cold group.

NCT ID: NCT01438502 Withdrawn - Fluid Overload Clinical Trials

"The Effect of Reduced Fluid Load After Cardiac Surgery"

Start date: n/a
Phase: Phase 0
Study type: Observational

The purpose of this study is to verify that an infusion of hypertonic saline/colloids during cardio-pulmonary-bypass will reduce fluid overload and organ edema for cardiac patients with expected long-CPB-time. Expected beneficial effects are improved organ function for heart and lungs.